Table 3.
Characteristics | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Hazard Ratio | 95% CI | p-Value | Hazard Ratio | 95% CI | p-Value | |
Number of liver tumors at 1st diagnosis | ||||||
1.103 | 1.045–1.163 | 0.0003 | 1.095 | 1.035–1.158 | 0.0016 | |
Greatest dimension of liver tumor | ||||||
1.034 | 0.954–1.056 | 0.8781 | 0.999 | 0.947–1.054 | 0.9685 | |
Development of extra-hepatic metastatic disease | ||||||
No | 1.00 | 1.00 | ||||
Yes | 2.03 | 1.49–2.78 | <0.0001 | 2.10 | 1.50–2.93 | <0.0001 |
Development of pulmonary metastasis | ||||||
No | 1.00 | 1.00 | ||||
Yes | 2.02 | 1.50–2.72 | <0.0001 | 2.01 | 1.46–2.93 | <0.0001 |
Liver metastasis recurrence | ||||||
No | 1.00 | 1.00 | ||||
Yes | 1.37 | 0.99–1.89 | 0.0543 | 1.35 | 0.96–1.90 | 0.0866 |
Multiple of extra-hepatic metastatic site | ||||||
No | 1.00 | 1.00 | ||||
Yes | 2.09 | 1.57–2.77 | <0.0001 | 2.16 | 1.60–2.91 | <0.0001 |
Resection with and without BEV | ||||||
Chemo-naive | 1.00 | 1.00 | ||||
Neoadjuvent | 1.89 | 1.27–2.80 | 0.0018 | 1.61 | 1.07–2.42 | 0.0230 |
BEV | 1.27 | 0.83–1.95 | 0.2748 | 1.07 | 0.68–1.69 | 0.7589 |
Models are all adjusted for age at first diagnosis, gender, and BMI. Significant values are highlighted in bold.